PubMed:19749203
Annnotations
Glycan-Motif
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 245-249 | https://glytoucan.org/Structures/Glycans/G46677TE | denotes | GD1a |
T2 | 245-249 | https://glytoucan.org/Structures/Glycans/G69277LC | denotes | GD1a |
T3 | 1223-1234 | https://glytoucan.org/Structures/Glycans/G81533KY | denotes | sialic acid |
T4 | 1386-1390 | https://glytoucan.org/Structures/Glycans/G46677TE | denotes | GD1a |
T5 | 1386-1390 | https://glytoucan.org/Structures/Glycans/G69277LC | denotes | GD1a |
Inflammaging
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-105 | Sentence | denotes | Mammalian cell ganglioside-binding specificities of E. coli enterotoxins LT-IIb and variant LT-IIb(T13I). |
T2 | 106-250 | Sentence | denotes | LT-IIb, a type II heat-labile enterotoxin of Escherichia coli, is a potent immunologic adjuvant with high affinity binding for ganglioside GD1a. |
T3 | 251-369 | Sentence | denotes | Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc. |
T4 | 370-450 | Sentence | denotes | However, studies in our laboratory suggested a less restrictive binding epitope. |
T5 | 451-613 | Sentence | denotes | LT-IIb(T13I), an LT-IIb variant, engineered by a single isoleucine-threonine substitution, retains biological activity, but with less robust inflammatory effects. |
T6 | 614-823 | Sentence | denotes | We theorized that LT-IIb has a less restrictive binding epitope than previously proposed and that immunologic differences between LT-IIb and LT-IIb (T13I) correlate with subtle ganglioside binding differences. |
T7 | 824-1067 | Sentence | denotes | Ganglioside binding epitopes, determined by affinity overlay immunoblotting and enzymatic degradation of ganglioside components of RAW264.7 macrophages, indicated that LT-IIb bound to a broader array of gangliosides than previously recognized. |
T8 | 1068-1162 | Sentence | denotes | Each possessed NeuAcalpha2-3Galbeta1-3GalNAc, although not necessarily as a terminal sequence. |
T9 | 1163-1287 | Sentence | denotes | Rather, each had a requisite terminal or penultimate single sialic acid and binding was independent of ceramide composition. |
T10 | 1288-1462 | Sentence | denotes | RAW264.7 enterotoxin-binding and non-binding ganglioside epitopes were definitively identified as GD1a and GM1a, respectively, by enzymatic degradation and mass spectroscopy. |
T11 | 1463-1679 | Sentence | denotes | Affinity overlay immunoblots, constructed to the diverse array of known ganglioside structures of murine peritoneal macrophages, established that LT-IIb bound NeuAc- and NeuGc-gangliosides with nearly equal affinity. |
T12 | 1680-1782 | Sentence | denotes | However, LT-IIb(T13I) exhibited enhanced affinity for NeuGc-gangliosides and more restrictive binding. |
T13 | 1783-1969 | Sentence | denotes | These studies further elucidate the binding epitope for LT-IIb and suggest that the diminished inflammatory activity of LT-IIb(T13I) is mediated by a subtle shift in ganglioside binding. |
T14 | 1970-2072 | Sentence | denotes | These studies underscore the high degree of specificity required for ganglioside-protein interactions. |
T1 | 0-105 | Sentence | denotes | Mammalian cell ganglioside-binding specificities of E. coli enterotoxins LT-IIb and variant LT-IIb(T13I). |
T2 | 106-250 | Sentence | denotes | LT-IIb, a type II heat-labile enterotoxin of Escherichia coli, is a potent immunologic adjuvant with high affinity binding for ganglioside GD1a. |
T3 | 251-369 | Sentence | denotes | Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc. |
T4 | 370-450 | Sentence | denotes | However, studies in our laboratory suggested a less restrictive binding epitope. |
T5 | 451-613 | Sentence | denotes | LT-IIb(T13I), an LT-IIb variant, engineered by a single isoleucine-threonine substitution, retains biological activity, but with less robust inflammatory effects. |
T6 | 614-823 | Sentence | denotes | We theorized that LT-IIb has a less restrictive binding epitope than previously proposed and that immunologic differences between LT-IIb and LT-IIb (T13I) correlate with subtle ganglioside binding differences. |
T7 | 824-1067 | Sentence | denotes | Ganglioside binding epitopes, determined by affinity overlay immunoblotting and enzymatic degradation of ganglioside components of RAW264.7 macrophages, indicated that LT-IIb bound to a broader array of gangliosides than previously recognized. |
T8 | 1068-1162 | Sentence | denotes | Each possessed NeuAcalpha2-3Galbeta1-3GalNAc, although not necessarily as a terminal sequence. |
T9 | 1163-1287 | Sentence | denotes | Rather, each had a requisite terminal or penultimate single sialic acid and binding was independent of ceramide composition. |
T10 | 1288-1462 | Sentence | denotes | RAW264.7 enterotoxin-binding and non-binding ganglioside epitopes were definitively identified as GD1a and GM1a, respectively, by enzymatic degradation and mass spectroscopy. |
T11 | 1463-1679 | Sentence | denotes | Affinity overlay immunoblots, constructed to the diverse array of known ganglioside structures of murine peritoneal macrophages, established that LT-IIb bound NeuAc- and NeuGc-gangliosides with nearly equal affinity. |
T12 | 1680-1782 | Sentence | denotes | However, LT-IIb(T13I) exhibited enhanced affinity for NeuGc-gangliosides and more restrictive binding. |
T13 | 1783-1969 | Sentence | denotes | These studies further elucidate the binding epitope for LT-IIb and suggest that the diminished inflammatory activity of LT-IIb(T13I) is mediated by a subtle shift in ganglioside binding. |
T14 | 1970-2072 | Sentence | denotes | These studies underscore the high degree of specificity required for ganglioside-protein interactions. |
GlyCosmos6-Glycan-Motif-Image
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 245-249 | Glycan_Motif | denotes | GD1a | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G69277LC|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46677TE |
T3 | 1223-1234 | Glycan_Motif | denotes | sialic acid | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY |
T4 | 1386-1390 | Glycan_Motif | denotes | GD1a | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G69277LC|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46677TE |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-105 | Sentence | denotes | Mammalian cell ganglioside-binding specificities of E. coli enterotoxins LT-IIb and variant LT-IIb(T13I). |
TextSentencer_T2 | 106-250 | Sentence | denotes | LT-IIb, a type II heat-labile enterotoxin of Escherichia coli, is a potent immunologic adjuvant with high affinity binding for ganglioside GD1a. |
TextSentencer_T3 | 251-369 | Sentence | denotes | Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc. |
TextSentencer_T4 | 370-450 | Sentence | denotes | However, studies in our laboratory suggested a less restrictive binding epitope. |
TextSentencer_T5 | 451-613 | Sentence | denotes | LT-IIb(T13I), an LT-IIb variant, engineered by a single isoleucine-threonine substitution, retains biological activity, but with less robust inflammatory effects. |
TextSentencer_T6 | 614-823 | Sentence | denotes | We theorized that LT-IIb has a less restrictive binding epitope than previously proposed and that immunologic differences between LT-IIb and LT-IIb (T13I) correlate with subtle ganglioside binding differences. |
TextSentencer_T7 | 824-1067 | Sentence | denotes | Ganglioside binding epitopes, determined by affinity overlay immunoblotting and enzymatic degradation of ganglioside components of RAW264.7 macrophages, indicated that LT-IIb bound to a broader array of gangliosides than previously recognized. |
TextSentencer_T8 | 1068-1162 | Sentence | denotes | Each possessed NeuAcalpha2-3Galbeta1-3GalNAc, although not necessarily as a terminal sequence. |
TextSentencer_T9 | 1163-1287 | Sentence | denotes | Rather, each had a requisite terminal or penultimate single sialic acid and binding was independent of ceramide composition. |
TextSentencer_T10 | 1288-1462 | Sentence | denotes | RAW264.7 enterotoxin-binding and non-binding ganglioside epitopes were definitively identified as GD1a and GM1a, respectively, by enzymatic degradation and mass spectroscopy. |
TextSentencer_T11 | 1463-1679 | Sentence | denotes | Affinity overlay immunoblots, constructed to the diverse array of known ganglioside structures of murine peritoneal macrophages, established that LT-IIb bound NeuAc- and NeuGc-gangliosides with nearly equal affinity. |
TextSentencer_T12 | 1680-1782 | Sentence | denotes | However, LT-IIb(T13I) exhibited enhanced affinity for NeuGc-gangliosides and more restrictive binding. |
TextSentencer_T13 | 1783-1969 | Sentence | denotes | These studies further elucidate the binding epitope for LT-IIb and suggest that the diminished inflammatory activity of LT-IIb(T13I) is mediated by a subtle shift in ganglioside binding. |
TextSentencer_T14 | 1970-2072 | Sentence | denotes | These studies underscore the high degree of specificity required for ganglioside-protein interactions. |
T1 | 0-105 | Sentence | denotes | Mammalian cell ganglioside-binding specificities of E. coli enterotoxins LT-IIb and variant LT-IIb(T13I). |
T2 | 106-250 | Sentence | denotes | LT-IIb, a type II heat-labile enterotoxin of Escherichia coli, is a potent immunologic adjuvant with high affinity binding for ganglioside GD1a. |
T3 | 251-369 | Sentence | denotes | Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc. |
T4 | 370-450 | Sentence | denotes | However, studies in our laboratory suggested a less restrictive binding epitope. |
T5 | 451-613 | Sentence | denotes | LT-IIb(T13I), an LT-IIb variant, engineered by a single isoleucine-threonine substitution, retains biological activity, but with less robust inflammatory effects. |
T6 | 614-823 | Sentence | denotes | We theorized that LT-IIb has a less restrictive binding epitope than previously proposed and that immunologic differences between LT-IIb and LT-IIb (T13I) correlate with subtle ganglioside binding differences. |
T7 | 824-1067 | Sentence | denotes | Ganglioside binding epitopes, determined by affinity overlay immunoblotting and enzymatic degradation of ganglioside components of RAW264.7 macrophages, indicated that LT-IIb bound to a broader array of gangliosides than previously recognized. |
T8 | 1068-1162 | Sentence | denotes | Each possessed NeuAcalpha2-3Galbeta1-3GalNAc, although not necessarily as a terminal sequence. |
T9 | 1163-1287 | Sentence | denotes | Rather, each had a requisite terminal or penultimate single sialic acid and binding was independent of ceramide composition. |
T10 | 1288-1462 | Sentence | denotes | RAW264.7 enterotoxin-binding and non-binding ganglioside epitopes were definitively identified as GD1a and GM1a, respectively, by enzymatic degradation and mass spectroscopy. |
T11 | 1463-1679 | Sentence | denotes | Affinity overlay immunoblots, constructed to the diverse array of known ganglioside structures of murine peritoneal macrophages, established that LT-IIb bound NeuAc- and NeuGc-gangliosides with nearly equal affinity. |
T12 | 1680-1782 | Sentence | denotes | However, LT-IIb(T13I) exhibited enhanced affinity for NeuGc-gangliosides and more restrictive binding. |
T13 | 1783-1969 | Sentence | denotes | These studies further elucidate the binding epitope for LT-IIb and suggest that the diminished inflammatory activity of LT-IIb(T13I) is mediated by a subtle shift in ganglioside binding. |
T14 | 1970-2072 | Sentence | denotes | These studies underscore the high degree of specificity required for ganglioside-protein interactions. |
T1 | 0-105 | Sentence | denotes | Mammalian cell ganglioside-binding specificities of E. coli enterotoxins LT-IIb and variant LT-IIb(T13I). |
T2 | 106-250 | Sentence | denotes | LT-IIb, a type II heat-labile enterotoxin of Escherichia coli, is a potent immunologic adjuvant with high affinity binding for ganglioside GD1a. |
T3 | 251-369 | Sentence | denotes | Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc. |
T4 | 370-450 | Sentence | denotes | However, studies in our laboratory suggested a less restrictive binding epitope. |
T5 | 451-613 | Sentence | denotes | LT-IIb(T13I), an LT-IIb variant, engineered by a single isoleucine-threonine substitution, retains biological activity, but with less robust inflammatory effects. |
T6 | 614-823 | Sentence | denotes | We theorized that LT-IIb has a less restrictive binding epitope than previously proposed and that immunologic differences between LT-IIb and LT-IIb (T13I) correlate with subtle ganglioside binding differences. |
T7 | 824-1067 | Sentence | denotes | Ganglioside binding epitopes, determined by affinity overlay immunoblotting and enzymatic degradation of ganglioside components of RAW264.7 macrophages, indicated that LT-IIb bound to a broader array of gangliosides than previously recognized. |
T8 | 1068-1162 | Sentence | denotes | Each possessed NeuAcalpha2-3Galbeta1-3GalNAc, although not necessarily as a terminal sequence. |
T9 | 1163-1287 | Sentence | denotes | Rather, each had a requisite terminal or penultimate single sialic acid and binding was independent of ceramide composition. |
T10 | 1288-1462 | Sentence | denotes | RAW264.7 enterotoxin-binding and non-binding ganglioside epitopes were definitively identified as GD1a and GM1a, respectively, by enzymatic degradation and mass spectroscopy. |
T11 | 1463-1679 | Sentence | denotes | Affinity overlay immunoblots, constructed to the diverse array of known ganglioside structures of murine peritoneal macrophages, established that LT-IIb bound NeuAc- and NeuGc-gangliosides with nearly equal affinity. |
T12 | 1680-1782 | Sentence | denotes | However, LT-IIb(T13I) exhibited enhanced affinity for NeuGc-gangliosides and more restrictive binding. |
T13 | 1783-1969 | Sentence | denotes | These studies further elucidate the binding epitope for LT-IIb and suggest that the diminished inflammatory activity of LT-IIb(T13I) is mediated by a subtle shift in ganglioside binding. |
T14 | 1970-2072 | Sentence | denotes | These studies underscore the high degree of specificity required for ganglioside-protein interactions. |
GlyCosmos6-Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 245-249 | https://glytoucan.org/Structures/Glycans/G46677TE | denotes | GD1a |
T2 | 245-249 | https://glytoucan.org/Structures/Glycans/G69277LC | denotes | GD1a |
T3 | 1223-1234 | https://glytoucan.org/Structures/Glycans/G81533KY | denotes | sialic acid |
T4 | 1386-1390 | https://glytoucan.org/Structures/Glycans/G46677TE | denotes | GD1a |
T5 | 1386-1390 | https://glytoucan.org/Structures/Glycans/G69277LC | denotes | GD1a |
Glycosmos6-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 245-249 | http://www.glycoepitope.jp/epitopes/EP0056 | denotes | GD1a |
T2 | 1386-1390 | http://www.glycoepitope.jp/epitopes/EP0056 | denotes | GD1a |
GlycoBiology-PACDB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
_T1 | 151-167 | http://acgg.asia/db/diseases/pacdb/lec?ids=LEC002,LEC056,LEC062,LEC069,LEC081,LEC111,LEC133,LEC171,LEC177,LEC187,LEC211,LEC242,LEC252,LEC258,LEC259,LEC260,LEC262,LEC369,LEC377,LEC422,LEC442,LEC448,LEC450,LEC451,LEC454,LEC472,LEC492,LEC620 | denotes | Escherichia coli |
_T2 | 151-167 | http://acgg.asia/db/diseases/pacdb/lec?ids=LEC157,LEC407 | denotes | Escherichia coli |
_T3 | 151-167 | http://acgg.asia/db/diseases/pacdb/lec?ids=LEC754 | denotes | Escherichia coli |
_T4 | 151-167 | http://acgg.asia/db/diseases/pacdb/lec?ids=LEC243,LEC640 | denotes | Escherichia coli |
_T5 | 151-167 | http://acgg.asia/db/diseases/pacdb/lec?ids=LEC295,LEC417 | denotes | Escherichia coli |
_T6 | 151-167 | http://acgg.asia/db/diseases/pacdb/lec?ids=LEC487 | denotes | Escherichia coli |
_T7 | 151-167 | http://acgg.asia/db/diseases/pacdb/lec?ids=LEC244,LEC256,LEC354 | denotes | Escherichia coli |
_T8 | 151-167 | http://acgg.asia/db/diseases/pacdb/lec?ids=LEC054,LEC058,LEC073,LEC082,LEC091,LEC103,LEC109,LEC110,LEC123,LEC158,LEC179,LEC198,LEC205,LEC222,LEC223,LEC224,LEC225,LEC232,LEC298,LEC357,LEC378,LEC383,LEC388,LEC389,LEC397,LEC401,LEC410,LEC452 | denotes | Escherichia coli |
_T9 | 151-167 | http://acgg.asia/db/diseases/pacdb/lec?ids=LEC636 | denotes | Escherichia coli |
ICD10
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 1568-1578 | http://purl.bioontology.org/ontology/ICD10/K65.9 | denotes | peritoneal |
T2 | 1568-1578 | http://purl.bioontology.org/ontology/ICD10/K65 | denotes | peritoneal |
GlycoBiology-FMA
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
_T1 | 15-26 | FMAID:82816 | denotes | ganglioside |
_T2 | 15-26 | FMAID:196811 | denotes | ganglioside |
_T3 | 233-244 | FMAID:82816 | denotes | ganglioside |
_T4 | 233-244 | FMAID:196811 | denotes | ganglioside |
_T5 | 324-329 | FMAID:196724 | denotes | sugar |
_T6 | 507-517 | FMAID:196745 | denotes | isoleucine |
_T7 | 507-517 | FMAID:82756 | denotes | isoleucine |
_T8 | 518-527 | FMAID:82765 | denotes | threonine |
_T9 | 518-527 | FMAID:196754 | denotes | threonine |
_T10 | 791-802 | FMAID:82816 | denotes | ganglioside |
_T11 | 791-802 | FMAID:196811 | denotes | ganglioside |
_T12 | 824-835 | FMAID:82816 | denotes | Ganglioside |
_T13 | 824-835 | FMAID:196811 | denotes | Ganglioside |
_T14 | 929-940 | FMAID:82816 | denotes | ganglioside |
_T15 | 929-940 | FMAID:196811 | denotes | ganglioside |
_T16 | 964-975 | FMAID:167685 | denotes | macrophages |
_T17 | 964-975 | FMAID:63261 | denotes | macrophages |
_T18 | 1027-1039 | FMAID:82816 | denotes | gangliosides |
_T19 | 1027-1039 | FMAID:196811 | denotes | gangliosides |
_T20 | 1275-1286 | FMAID:50603 | denotes | composition |
_T21 | 1275-1286 | FMAID:146309 | denotes | composition |
_T22 | 1333-1344 | FMAID:196811 | denotes | ganglioside |
_T23 | 1333-1344 | FMAID:82816 | denotes | ganglioside |
_T24 | 1535-1546 | FMAID:82816 | denotes | ganglioside |
_T25 | 1535-1546 | FMAID:196811 | denotes | ganglioside |
_T26 | 1568-1590 | FMAID:83025 | denotes | peritoneal macrophages |
_T27 | 1568-1590 | FMAID:197284 | denotes | peritoneal macrophages |
_T28 | 1579-1590 | FMAID:167685 | denotes | macrophages |
_T29 | 1579-1590 | FMAID:63261 | denotes | macrophages |
_T30 | 1639-1651 | FMAID:196811 | denotes | gangliosides |
_T31 | 1639-1651 | FMAID:82816 | denotes | gangliosides |
_T32 | 1740-1752 | FMAID:82816 | denotes | gangliosides |
_T33 | 1740-1752 | FMAID:196811 | denotes | gangliosides |
_T34 | 1949-1960 | FMAID:196811 | denotes | ganglioside |
_T35 | 1949-1960 | FMAID:82816 | denotes | ganglioside |
_T36 | 2039-2050 | FMAID:196811 | denotes | ganglioside |
_T37 | 2039-2050 | FMAID:82816 | denotes | ganglioside |
_T38 | 2051-2058 | FMAID:67257 | denotes | protein |
_T39 | 2051-2058 | FMAID:165447 | denotes | protein |
GlycoBiology-NCBITAXON
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 151-162 | http://purl.bioontology.org/ontology/NCBITAXON/561 | denotes | Escherichia |
T2 | 1321-1324 | http://purl.bioontology.org/ontology/NCBITAXON/604139 | denotes | non |
GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 914-925 | http://purl.obolibrary.org/obo/GO_0009056 | denotes | degradation |
T2 | 1428-1439 | http://purl.obolibrary.org/obo/GO_0009056 | denotes | degradation |
T3 | 914-940 | http://purl.obolibrary.org/obo/GO_0006689 | denotes | degradation of ganglioside |
GO-MF
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 27-34 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T2 | 221-228 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T3 | 434-441 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T4 | 662-669 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T5 | 803-810 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T6 | 836-843 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T7 | 1239-1246 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T8 | 1309-1316 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T9 | 1325-1332 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T10 | 1774-1781 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T11 | 1819-1826 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T12 | 1961-1968 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T13 | 27-34 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T14 | 221-228 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T15 | 434-441 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T16 | 662-669 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T17 | 803-810 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T18 | 836-843 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T19 | 1239-1246 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T20 | 1309-1316 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T21 | 1325-1332 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T22 | 1774-1781 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T23 | 1819-1826 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T24 | 1961-1968 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T25 | 27-34 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T26 | 221-228 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T27 | 434-441 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T28 | 662-669 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T29 | 803-810 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T30 | 836-843 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T31 | 1239-1246 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T32 | 1309-1316 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T33 | 1325-1332 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T34 | 1774-1781 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T35 | 1819-1826 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T36 | 1961-1968 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T37 | 27-34 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
T38 | 221-228 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
T39 | 434-441 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
T40 | 662-669 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
T41 | 803-810 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
T42 | 836-843 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
T43 | 1239-1246 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
T44 | 1309-1316 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
T45 | 1325-1332 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
T46 | 1774-1781 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
T47 | 1819-1826 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
T48 | 1961-1968 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
GO-CC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 10-14 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
GlycoBiology-Epitope
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
PD-GlycoEpitope-B_T1 | 245-249 | http://www.glycoepitope.jp/epitopes/EP0056 | denotes | GD1a |
PD-GlycoEpitope-B_T2 | 1386-1390 | http://www.glycoepitope.jp/epitopes/EP0056 | denotes | GD1a |
GlyTouCan-IUPAC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
GlycanIUPAC_T1 | 324-329 | "http://rdf.glycoinfo.org/glycan/G59665TO" | denotes | sugar |
GlycanIUPAC_T2 | 324-329 | "http://rdf.glycoinfo.org/glycan/G32915EI" | denotes | sugar |
GlycanIUPAC_T3 | 324-329 | "http://rdf.glycoinfo.org/glycan/G60625TS" | denotes | sugar |
GlycanIUPAC_T4 | 1321-1324 | "http://rdf.glycoinfo.org/glycan/G02780QX" | denotes | non |
GlycanIUPAC_T5 | 1321-1324 | "http://rdf.glycoinfo.org/glycan/G18425DX" | denotes | non |
GlycanIUPAC_T6 | 1321-1324 | "http://rdf.glycoinfo.org/glycan/G18630JE" | denotes | non |
GlycanIUPAC_T7 | 1321-1324 | "http://rdf.glycoinfo.org/glycan/G01004IT" | denotes | non |
GlycanIUPAC_T8 | 1321-1324 | "http://rdf.glycoinfo.org/glycan/G87301QZ" | denotes | non |
GlycanIUPAC_T9 | 1321-1324 | "http://rdf.glycoinfo.org/glycan/G39790GW" | denotes | non |
GlycanIUPAC_T10 | 1321-1324 | "http://rdf.glycoinfo.org/glycan/G42928BB" | denotes | non |
GlycanIUPAC_T11 | 1321-1324 | "http://rdf.glycoinfo.org/glycan/G51134HC" | denotes | non |
GlycanIUPAC_T12 | 1321-1324 | "http://rdf.glycoinfo.org/glycan/G68183GR" | denotes | non |
GlycanIUPAC_T13 | 1321-1324 | "http://rdf.glycoinfo.org/glycan/G46883FA" | denotes | non |
GlycanIUPAC_T14 | 1321-1324 | "http://rdf.glycoinfo.org/glycan/G54702VY" | denotes | non |
Glycan-GlyCosmos
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 245-249 | Glycan | denotes | GD1a | https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE |
T2 | 1386-1390 | Glycan | denotes | GD1a | https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE |
T3 | 1395-1399 | Glycan | denotes | GM1a | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T4 | 1622-1627 | Glycan | denotes | NeuAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR |
GlyCosmos-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
---|---|---|---|---|---|
T1 | 245-249 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GD1a | http://www.glycoepitope.jp/epitopes/EP0056 |
T2 | 1386-1390 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GD1a | http://www.glycoepitope.jp/epitopes/EP0056 |
GlyCosmos15-NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 52-59 | OrganismTaxon | denotes | E. coli | 562 |
T2 | 151-167 | OrganismTaxon | denotes | Escherichia coli | 562 |
GlyCosmos15-CL
Id | Subject | Object | Predicate | Lexical cue | cl_id |
---|---|---|---|---|---|
T1 | 964-975 | Cell | denotes | macrophages | http://purl.obolibrary.org/obo/CL:0000235|http://purl.obolibrary.org/obo/CL:0000394 |
T3 | 1568-1590 | Cell | denotes | peritoneal macrophages | http://purl.obolibrary.org/obo/CL:0000581 |
GlyCosmos15-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 964-975 | Body_part | denotes | macrophages | http://purl.obolibrary.org/obo/CL_0000235 |
T2 | 1579-1590 | Body_part | denotes | macrophages | http://purl.obolibrary.org/obo/CL_0000235 |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-105 | Sentence | denotes | Mammalian cell ganglioside-binding specificities of E. coli enterotoxins LT-IIb and variant LT-IIb(T13I). |
TextSentencer_T2 | 106-250 | Sentence | denotes | LT-IIb, a type II heat-labile enterotoxin of Escherichia coli, is a potent immunologic adjuvant with high affinity binding for ganglioside GD1a. |
TextSentencer_T3 | 251-369 | Sentence | denotes | Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc. |
TextSentencer_T4 | 370-450 | Sentence | denotes | However, studies in our laboratory suggested a less restrictive binding epitope. |
TextSentencer_T5 | 451-613 | Sentence | denotes | LT-IIb(T13I), an LT-IIb variant, engineered by a single isoleucine-threonine substitution, retains biological activity, but with less robust inflammatory effects. |
TextSentencer_T6 | 614-823 | Sentence | denotes | We theorized that LT-IIb has a less restrictive binding epitope than previously proposed and that immunologic differences between LT-IIb and LT-IIb (T13I) correlate with subtle ganglioside binding differences. |
TextSentencer_T7 | 824-1067 | Sentence | denotes | Ganglioside binding epitopes, determined by affinity overlay immunoblotting and enzymatic degradation of ganglioside components of RAW264.7 macrophages, indicated that LT-IIb bound to a broader array of gangliosides than previously recognized. |
TextSentencer_T8 | 1068-1162 | Sentence | denotes | Each possessed NeuAcalpha2-3Galbeta1-3GalNAc, although not necessarily as a terminal sequence. |
TextSentencer_T9 | 1163-1287 | Sentence | denotes | Rather, each had a requisite terminal or penultimate single sialic acid and binding was independent of ceramide composition. |
TextSentencer_T10 | 1288-1462 | Sentence | denotes | RAW264.7 enterotoxin-binding and non-binding ganglioside epitopes were definitively identified as GD1a and GM1a, respectively, by enzymatic degradation and mass spectroscopy. |
TextSentencer_T11 | 1463-1679 | Sentence | denotes | Affinity overlay immunoblots, constructed to the diverse array of known ganglioside structures of murine peritoneal macrophages, established that LT-IIb bound NeuAc- and NeuGc-gangliosides with nearly equal affinity. |
TextSentencer_T12 | 1680-1782 | Sentence | denotes | However, LT-IIb(T13I) exhibited enhanced affinity for NeuGc-gangliosides and more restrictive binding. |
TextSentencer_T13 | 1783-1969 | Sentence | denotes | These studies further elucidate the binding epitope for LT-IIb and suggest that the diminished inflammatory activity of LT-IIb(T13I) is mediated by a subtle shift in ganglioside binding. |
TextSentencer_T14 | 1970-2072 | Sentence | denotes | These studies underscore the high degree of specificity required for ganglioside-protein interactions. |
T1 | 0-105 | Sentence | denotes | Mammalian cell ganglioside-binding specificities of E. coli enterotoxins LT-IIb and variant LT-IIb(T13I). |
T2 | 106-250 | Sentence | denotes | LT-IIb, a type II heat-labile enterotoxin of Escherichia coli, is a potent immunologic adjuvant with high affinity binding for ganglioside GD1a. |
T3 | 251-369 | Sentence | denotes | Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc. |
T4 | 370-450 | Sentence | denotes | However, studies in our laboratory suggested a less restrictive binding epitope. |
T5 | 451-613 | Sentence | denotes | LT-IIb(T13I), an LT-IIb variant, engineered by a single isoleucine-threonine substitution, retains biological activity, but with less robust inflammatory effects. |
T6 | 614-823 | Sentence | denotes | We theorized that LT-IIb has a less restrictive binding epitope than previously proposed and that immunologic differences between LT-IIb and LT-IIb (T13I) correlate with subtle ganglioside binding differences. |
T7 | 824-1067 | Sentence | denotes | Ganglioside binding epitopes, determined by affinity overlay immunoblotting and enzymatic degradation of ganglioside components of RAW264.7 macrophages, indicated that LT-IIb bound to a broader array of gangliosides than previously recognized. |
T8 | 1068-1162 | Sentence | denotes | Each possessed NeuAcalpha2-3Galbeta1-3GalNAc, although not necessarily as a terminal sequence. |
T9 | 1163-1287 | Sentence | denotes | Rather, each had a requisite terminal or penultimate single sialic acid and binding was independent of ceramide composition. |
T10 | 1288-1462 | Sentence | denotes | RAW264.7 enterotoxin-binding and non-binding ganglioside epitopes were definitively identified as GD1a and GM1a, respectively, by enzymatic degradation and mass spectroscopy. |
T11 | 1463-1679 | Sentence | denotes | Affinity overlay immunoblots, constructed to the diverse array of known ganglioside structures of murine peritoneal macrophages, established that LT-IIb bound NeuAc- and NeuGc-gangliosides with nearly equal affinity. |
T12 | 1680-1782 | Sentence | denotes | However, LT-IIb(T13I) exhibited enhanced affinity for NeuGc-gangliosides and more restrictive binding. |
T13 | 1783-1969 | Sentence | denotes | These studies further elucidate the binding epitope for LT-IIb and suggest that the diminished inflammatory activity of LT-IIb(T13I) is mediated by a subtle shift in ganglioside binding. |
T14 | 1970-2072 | Sentence | denotes | These studies underscore the high degree of specificity required for ganglioside-protein interactions. |
T1 | 0-105 | Sentence | denotes | Mammalian cell ganglioside-binding specificities of E. coli enterotoxins LT-IIb and variant LT-IIb(T13I). |
T2 | 106-250 | Sentence | denotes | LT-IIb, a type II heat-labile enterotoxin of Escherichia coli, is a potent immunologic adjuvant with high affinity binding for ganglioside GD1a. |
T3 | 251-369 | Sentence | denotes | Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc. |
T4 | 370-450 | Sentence | denotes | However, studies in our laboratory suggested a less restrictive binding epitope. |
T5 | 451-613 | Sentence | denotes | LT-IIb(T13I), an LT-IIb variant, engineered by a single isoleucine-threonine substitution, retains biological activity, but with less robust inflammatory effects. |
T6 | 614-823 | Sentence | denotes | We theorized that LT-IIb has a less restrictive binding epitope than previously proposed and that immunologic differences between LT-IIb and LT-IIb (T13I) correlate with subtle ganglioside binding differences. |
T7 | 824-1067 | Sentence | denotes | Ganglioside binding epitopes, determined by affinity overlay immunoblotting and enzymatic degradation of ganglioside components of RAW264.7 macrophages, indicated that LT-IIb bound to a broader array of gangliosides than previously recognized. |
T8 | 1068-1162 | Sentence | denotes | Each possessed NeuAcalpha2-3Galbeta1-3GalNAc, although not necessarily as a terminal sequence. |
T9 | 1163-1287 | Sentence | denotes | Rather, each had a requisite terminal or penultimate single sialic acid and binding was independent of ceramide composition. |
T10 | 1288-1462 | Sentence | denotes | RAW264.7 enterotoxin-binding and non-binding ganglioside epitopes were definitively identified as GD1a and GM1a, respectively, by enzymatic degradation and mass spectroscopy. |
T11 | 1463-1679 | Sentence | denotes | Affinity overlay immunoblots, constructed to the diverse array of known ganglioside structures of murine peritoneal macrophages, established that LT-IIb bound NeuAc- and NeuGc-gangliosides with nearly equal affinity. |
T12 | 1680-1782 | Sentence | denotes | However, LT-IIb(T13I) exhibited enhanced affinity for NeuGc-gangliosides and more restrictive binding. |
T13 | 1783-1969 | Sentence | denotes | These studies further elucidate the binding epitope for LT-IIb and suggest that the diminished inflammatory activity of LT-IIb(T13I) is mediated by a subtle shift in ganglioside binding. |
T14 | 1970-2072 | Sentence | denotes | These studies underscore the high degree of specificity required for ganglioside-protein interactions. |
GlyCosmos15-Sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-105 | Sentence | denotes | Mammalian cell ganglioside-binding specificities of E. coli enterotoxins LT-IIb and variant LT-IIb(T13I). |
T2 | 106-250 | Sentence | denotes | LT-IIb, a type II heat-labile enterotoxin of Escherichia coli, is a potent immunologic adjuvant with high affinity binding for ganglioside GD1a. |
T3 | 251-369 | Sentence | denotes | Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc. |
T4 | 370-450 | Sentence | denotes | However, studies in our laboratory suggested a less restrictive binding epitope. |
T5 | 451-613 | Sentence | denotes | LT-IIb(T13I), an LT-IIb variant, engineered by a single isoleucine-threonine substitution, retains biological activity, but with less robust inflammatory effects. |
T6 | 614-823 | Sentence | denotes | We theorized that LT-IIb has a less restrictive binding epitope than previously proposed and that immunologic differences between LT-IIb and LT-IIb (T13I) correlate with subtle ganglioside binding differences. |
T7 | 824-1067 | Sentence | denotes | Ganglioside binding epitopes, determined by affinity overlay immunoblotting and enzymatic degradation of ganglioside components of RAW264.7 macrophages, indicated that LT-IIb bound to a broader array of gangliosides than previously recognized. |
T8 | 1068-1162 | Sentence | denotes | Each possessed NeuAcalpha2-3Galbeta1-3GalNAc, although not necessarily as a terminal sequence. |
T9 | 1163-1287 | Sentence | denotes | Rather, each had a requisite terminal or penultimate single sialic acid and binding was independent of ceramide composition. |
T10 | 1288-1462 | Sentence | denotes | RAW264.7 enterotoxin-binding and non-binding ganglioside epitopes were definitively identified as GD1a and GM1a, respectively, by enzymatic degradation and mass spectroscopy. |
T11 | 1463-1679 | Sentence | denotes | Affinity overlay immunoblots, constructed to the diverse array of known ganglioside structures of murine peritoneal macrophages, established that LT-IIb bound NeuAc- and NeuGc-gangliosides with nearly equal affinity. |
T12 | 1680-1782 | Sentence | denotes | However, LT-IIb(T13I) exhibited enhanced affinity for NeuGc-gangliosides and more restrictive binding. |
T13 | 1783-1969 | Sentence | denotes | These studies further elucidate the binding epitope for LT-IIb and suggest that the diminished inflammatory activity of LT-IIb(T13I) is mediated by a subtle shift in ganglioside binding. |
T14 | 1970-2072 | Sentence | denotes | These studies underscore the high degree of specificity required for ganglioside-protein interactions. |
GlyCosmos15-Glycan
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 245-249 | Glycan | denotes | GD1a | https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE |
T2 | 1386-1390 | Glycan | denotes | GD1a | https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE |
T3 | 1395-1399 | Glycan | denotes | GM1a | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T4 | 1622-1627 | Glycan | denotes | NeuAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR |
GlyCosmos15-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
---|---|---|---|---|---|
T1 | 245-249 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GD1a | http://www.glycoepitope.jp/epitopes/EP0056 |
T2 | 1386-1390 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GD1a | http://www.glycoepitope.jp/epitopes/EP0056 |
NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 52-59 | OrganismTaxon | denotes | E. coli | 562 |
T2 | 151-167 | OrganismTaxon | denotes | Escherichia coli | 562 |
Anatomy-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 964-975 | Body_part | denotes | macrophages | http://purl.obolibrary.org/obo/CL_0000235 |
T2 | 1579-1590 | Body_part | denotes | macrophages | http://purl.obolibrary.org/obo/CL_0000235 |
CL-cell
Id | Subject | Object | Predicate | Lexical cue | cl_id |
---|---|---|---|---|---|
T1 | 964-975 | Cell | denotes | macrophages | http://purl.obolibrary.org/obo/CL:0000235|http://purl.obolibrary.org/obo/CL:0000394 |
T3 | 1568-1590 | Cell | denotes | peritoneal macrophages | http://purl.obolibrary.org/obo/CL:0000581 |